|
Re: Sedar filings - Loan balance
|
3
|
Resverlogix Corp.
|
Jul 31, 2019 12:09PM
|
|
Resverlogix hacked
|
3
|
Resverlogix Corp.
|
Jan 18, 2016 11:06AM
|
|
Re: Richmond Club...
|
3
|
Resverlogix Corp.
|
Mar 24, 2016 03:40PM
|
|
Re: empagliflozin - a drug competitive to rvx-208???
|
3
|
Resverlogix Corp.
|
Nov 09, 2015 11:42AM
|
|
Re: Where's the kool aid gang?
|
3
|
Resverlogix Corp.
|
May 20, 2022 10:46AM
|
|
Re: one year vs two-year data
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 10:41AM
|
|
Re: ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
3
|
Resverlogix Corp.
|
Jul 06, 2019 01:53PM
|
|
Re: Maybe timing is everything…
|
3
|
Resverlogix Corp.
|
Jun 04, 2023 04:57PM
|
|
Re: New patent (January)
|
3
|
Resverlogix Corp.
|
Feb 24, 2016 06:55PM
|
|
Re: Response from Sarah -were still a go
|
3
|
Resverlogix Corp.
|
Dec 02, 2021 01:03PM
|
|
Re: At 1.33 we're over both the 20 and 50 DMAs....
|
3
|
Resverlogix Corp.
|
Jun 09, 2016 10:11AM
|
|
Question re BOD votes
|
3
|
Resverlogix Corp.
|
Jun 25, 2022 11:39AM
|
|
Qatar Research overview of apabetalone
|
3
|
Resverlogix Corp.
|
Apr 23, 2024 08:41PM
|
|
Re: Good Grief Charlie Brown….
|
3
|
Resverlogix Corp.
|
Jul 16, 2021 01:11PM
|
|
Re: A few things
|
3
|
Resverlogix Corp.
|
Oct 17, 2017 06:59PM
|
|
Re: Latest on COVID-19
|
3
|
Resverlogix Corp.
|
Sep 29, 2022 06:35PM
|
|
Re: Waiting for the shoe to drop....
|
3
|
Resverlogix Corp.
|
Apr 19, 2018 04:24PM
|
|
Analysts coverage
|
3
|
Resverlogix Corp.
|
Oct 07, 2017 11:36AM
|
|
Re: Zenith Presentation at AACR Meeting April 10-15
|
3
|
Zenith Epigenetics
|
Apr 11, 2021 11:30AM
|
|
Epigenetics article in Nature
|
3
|
Resverlogix Corp.
|
Dec 07, 2015 08:27AM
|
